 | Up a level |
Kanis, J A; Johansson, H; McCloskey, E V; Liu, E; Åkesson, K E; Anderson, F A; Azagra, R; Bager, C L; Beaudart, C; Bischoff-Ferrari, H A; Biver, E; Bruyère, O; Cauley, J A; Center, J R; Chapurlat, R; Christiansen, C; Cooper, C; Crandall, C J; Cummings, S R; da Silva, J A P; ... (2023). Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX. Osteoporosis international, 34(12), pp. 2027-2045. Springer-Verlag 10.1007/s00198-023-06870-z
Vandenput, L; Johansson, H; McCloskey, E V; Liu, E; Åkesson, K E; Anderson, F A; Azagra, R; Bager, C L; Beaudart, C; Bischoff-Ferrari, H A; Biver, E; Bruyère, O; Cauley, J A; Center, J R; Chapurlat, R; Christiansen, C; Cooper, C; Crandall, C J; Cummings, S R; da Silva, J A P; ... (2022). Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan. Osteoporosis international, 33(10), pp. 2103-2136. Springer-Verlag 10.1007/s00198-022-06435-6
McClung, M R; Lippuner, Kurt; Brandi, M L; Zanchetta, J R; Bone, H G; Chapurlat, R; Hans, D; Wang, A; Zapalowski, C; Libanati, C (2017). Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis. Osteoporosis international, 28(10), pp. 2967-2973. Springer 10.1007/s00198-017-4140-y
Senn, Christoph; Günther, Beatrice; Popp, Albrecht; Perrelet, Romain; Hans, D; Lippuner, Kurt (2014). Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study. Osteoporosis international, 25(7), pp. 1945-1951. Springer 10.1007/s00198-014-2703-8
Hans, D; Rizzoli, R; Thiébaud, D; Lippuner, K; Allaoua, S; Genton, L; Luzuy, F; Krieg, M A; Jaeger, P; Slosman, D O (2001). Reference data in a Swiss population. Discordance in patient classification using T-scores among calcaneum, spine, and femur. Journal of clinical densitometry, 4(4), pp. 291-8. New York, N.Y.: Elsevier 10.1385/JCD:4:4:291
